Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RDC-1036 in Opioid-induced Constipation
NCT01100151Phase 2Completed
- Sponsor
- Alkermes
- Start
- Apr 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of samidorphan in opioid-induced constipation (OIC), sponsored by Alkermes. Started Apr 2010; status: completed.
02
Drugs
samidorphan
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT01100151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01100151.